BNP Paribas Financial Markets
SANA icon

BNP Paribas Financial Markets’s Sana Biotechnology SANA Stock Holding History

BNP Paribas Financial Markets’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$165K Buy
57,118
+39,803
+230% +$157K ﹤0.01% 4136
2025
Q4 		$70.5K Sell
17,315
-50,021
-74% -$224K ﹤0.01% 4531
2025
Q3 		$239K Buy
67,336
+51,892
+336% +$188K ﹤0.01% 3925
2025
Q2 		$42.2K Buy
15,444
+4,931
+47% +$10.2K ﹤0.01% 4321
2025
Q1 		$17.7K Sell
10,513
-10,228
-49% -$28.6K ﹤0.01% 4571
2024
Q4 		$33.8K Buy
+20,741
New +$61.9K ﹤0.01% 4572
2022
Q4 		– Sell
-225,732
Closed -$1.35M – 4519
2022
Q3 		$1.35M Buy
+225,732
New +$1.63M ﹤0.01% 2247

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $9.64B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $1.89B AUM 112.84% 1-Year Est. Return